ALNY
Alnylam Pharmaceuticals, Inc.
Stock
$219.72−11.46 (−4.96%)Close Oct 2, 2026
Jun 1, 2004 – Oct 2, 2026, Dividends reinvested
- Final balance
- $313,886
- CAGR
- +16.68%
- Max drawdown
- −83.58%
- Sharpe ratio
- 0.55
Loading the growth chart…
Growth of $10,000
Trailing returns (%)
Annualized from 3Y- 1M
- −17.83%
- 3M
- −29.75%
- 6M
- −31.09%
- YTD
- −44.75%
- 1Y
- −52.34%
- 3Y
- +7.08%
- 5Y
- +2.66%
- 10Y
- +12.48%
- 15Y
- +26.36%
- 20Y
- +14.71%
- Since 2004
- +16.68%
Metrics
Since 2004| Volatility | 57.34% |
|---|---|
| Sortino ratio | 0.88 |
| Calmar ratio | 0.20 |
| Best year, 2013 | +252.33% |
| Worst year, 2016 | −60.23% |
| Positive years | 13 of 21 |
| Longest drawdown | 5.7 years |
Worst drawdowns
Since 2004| Decline | Peak | Bottom | Recovered | Length |
|---|---|---|---|---|
| −83.6% | Oct 2007 | Oct 2011 | Jul 2013 | 5.7 years |
| −77.4% | Jun 2015 | Nov 2016 | Nov 2017 | 2.4 years |
| −58.2% | Oct 2025 | Jul 2026 | Not yet | 11 months so far |
| −57.8% | Mar 2018 | Dec 2018 | Jun 2020 | 2.3 years |
| −52.2% | Jun 2004 | Aug 2004 | Jan 2005 | 7 months |
Annual returns
2004 from Jun 1 · 2026 through Oct 2